Baidu
map

Otol Neurotol:一个基于群体的耳硬化症发病率变化情况研究

2020-08-23 AlexYang MedSci原创

尽管在最近的几十年之间,人们认为耳硬化症越来越少见,而基于群体的数据并未对该趋势进行过鉴定。因为大多数的大规模流行病学数据主要是癌症数据,耳硬化的当代发生率还是未知。最近,有研究人员通过使用Roche

尽管在最近的几十年之间耳硬化症越来越少见,然而并没有基于群体的数据该趋势进行过证实。最近,有研究人员通过使用Rochester Epidemiology Project资源,鉴定了过去70年耳硬化发病率的趋势。

研究是一个基于群体的研究,数据的时间为1950年到2017年。研究发现,从1950年到2017年共发生了614例耳硬化病例。发病率从1950s的8.9/100000人增加到了1970到1974年间的峰值18.5/100000人。该峰值过后,发病率到1990s早期显著的减少到了6.2/100000人,并在2015年到2017年到达最低值3.4/100000人(p<0.001)。从1970年到2017年,诊断的年龄(p=0.23)和双侧案例的比例(p=0.16)均没有显著的变化;诊断时的纯音听觉阈值在研究期间也没有临床上的明显变化(均差<5dB,p=0.034)。

1950年到2017年的耳硬化发病率

最后,研究人员指出,耳硬化症从1970s早期急剧下降。历来耳硬化被认为是获得性听力损失最常见的原因之一,而当代美国的耳硬化的发病率较低,使得它在美国成为一种"罕见疾病"。另外,在确认培训者的案例需求和发展实践指南时,上述趋势还是需要考虑的。

原始出处:

John P Marinelli, Douglas J Totten, Kiran K Chauhan et al. The Rise and Fall of Otosclerosis: A Population-based Study of Disease Incidence Spanning 70 Years. Otol Neurotol. Aug 2020

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1668029, encodeId=68b11668029d9, content=<a href='/topic/show?id=1cf280498d2' target=_blank style='color:#2F92EE;'>#耳硬化症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80498, encryptionId=1cf280498d2, topicName=耳硬化症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f4726226525, createdName=jiyangfei, createdTime=Sat Jul 31 22:46:24 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823663, encodeId=5c8e182366324, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Wed Dec 09 01:46:24 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983131, encodeId=3cf41983131e0, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73594, encryptionId=a7a7e359478, topicName=硬化症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Sun Dec 20 08:46:24 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701464, encodeId=30451e01464a5, content=<a href='/topic/show?id=89fc8049e53' target=_blank style='color:#2F92EE;'>#耳硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80497, encryptionId=89fc8049e53, topicName=耳硬化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=515d30375051, createdName=jambiya, createdTime=Fri Sep 18 11:46:24 CST 2020, time=2020-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717043, encodeId=cd521e1704330, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Thu May 20 08:46:24 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814171, encodeId=3c9e8141e104, content=标记一下 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:53:09 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812792, encodeId=5537812e9265, content=耳硬化症发生率逐年在降低,是个好消息。, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Mon Aug 24 19:24:02 CST 2020, time=2020-08-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1668029, encodeId=68b11668029d9, content=<a href='/topic/show?id=1cf280498d2' target=_blank style='color:#2F92EE;'>#耳硬化症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80498, encryptionId=1cf280498d2, topicName=耳硬化症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f4726226525, createdName=jiyangfei, createdTime=Sat Jul 31 22:46:24 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823663, encodeId=5c8e182366324, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Wed Dec 09 01:46:24 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983131, encodeId=3cf41983131e0, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73594, encryptionId=a7a7e359478, topicName=硬化症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Sun Dec 20 08:46:24 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701464, encodeId=30451e01464a5, content=<a href='/topic/show?id=89fc8049e53' target=_blank style='color:#2F92EE;'>#耳硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80497, encryptionId=89fc8049e53, topicName=耳硬化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=515d30375051, createdName=jambiya, createdTime=Fri Sep 18 11:46:24 CST 2020, time=2020-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717043, encodeId=cd521e1704330, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Thu May 20 08:46:24 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814171, encodeId=3c9e8141e104, content=标记一下 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:53:09 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812792, encodeId=5537812e9265, content=耳硬化症发生率逐年在降低,是个好消息。, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Mon Aug 24 19:24:02 CST 2020, time=2020-08-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1668029, encodeId=68b11668029d9, content=<a href='/topic/show?id=1cf280498d2' target=_blank style='color:#2F92EE;'>#耳硬化症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80498, encryptionId=1cf280498d2, topicName=耳硬化症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f4726226525, createdName=jiyangfei, createdTime=Sat Jul 31 22:46:24 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823663, encodeId=5c8e182366324, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Wed Dec 09 01:46:24 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983131, encodeId=3cf41983131e0, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73594, encryptionId=a7a7e359478, topicName=硬化症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Sun Dec 20 08:46:24 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701464, encodeId=30451e01464a5, content=<a href='/topic/show?id=89fc8049e53' target=_blank style='color:#2F92EE;'>#耳硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80497, encryptionId=89fc8049e53, topicName=耳硬化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=515d30375051, createdName=jambiya, createdTime=Fri Sep 18 11:46:24 CST 2020, time=2020-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717043, encodeId=cd521e1704330, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Thu May 20 08:46:24 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814171, encodeId=3c9e8141e104, content=标记一下 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:53:09 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812792, encodeId=5537812e9265, content=耳硬化症发生率逐年在降低,是个好消息。, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Mon Aug 24 19:24:02 CST 2020, time=2020-08-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1668029, encodeId=68b11668029d9, content=<a href='/topic/show?id=1cf280498d2' target=_blank style='color:#2F92EE;'>#耳硬化症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80498, encryptionId=1cf280498d2, topicName=耳硬化症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f4726226525, createdName=jiyangfei, createdTime=Sat Jul 31 22:46:24 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823663, encodeId=5c8e182366324, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Wed Dec 09 01:46:24 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983131, encodeId=3cf41983131e0, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73594, encryptionId=a7a7e359478, topicName=硬化症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Sun Dec 20 08:46:24 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701464, encodeId=30451e01464a5, content=<a href='/topic/show?id=89fc8049e53' target=_blank style='color:#2F92EE;'>#耳硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80497, encryptionId=89fc8049e53, topicName=耳硬化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=515d30375051, createdName=jambiya, createdTime=Fri Sep 18 11:46:24 CST 2020, time=2020-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717043, encodeId=cd521e1704330, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Thu May 20 08:46:24 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814171, encodeId=3c9e8141e104, content=标记一下 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:53:09 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812792, encodeId=5537812e9265, content=耳硬化症发生率逐年在降低,是个好消息。, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Mon Aug 24 19:24:02 CST 2020, time=2020-08-24, status=1, ipAttribution=)]
    2020-09-18 jambiya
  5. [GetPortalCommentsPageByObjectIdResponse(id=1668029, encodeId=68b11668029d9, content=<a href='/topic/show?id=1cf280498d2' target=_blank style='color:#2F92EE;'>#耳硬化症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80498, encryptionId=1cf280498d2, topicName=耳硬化症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f4726226525, createdName=jiyangfei, createdTime=Sat Jul 31 22:46:24 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823663, encodeId=5c8e182366324, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Wed Dec 09 01:46:24 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983131, encodeId=3cf41983131e0, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73594, encryptionId=a7a7e359478, topicName=硬化症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Sun Dec 20 08:46:24 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701464, encodeId=30451e01464a5, content=<a href='/topic/show?id=89fc8049e53' target=_blank style='color:#2F92EE;'>#耳硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80497, encryptionId=89fc8049e53, topicName=耳硬化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=515d30375051, createdName=jambiya, createdTime=Fri Sep 18 11:46:24 CST 2020, time=2020-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717043, encodeId=cd521e1704330, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Thu May 20 08:46:24 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814171, encodeId=3c9e8141e104, content=标记一下 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:53:09 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812792, encodeId=5537812e9265, content=耳硬化症发生率逐年在降低,是个好消息。, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Mon Aug 24 19:24:02 CST 2020, time=2020-08-24, status=1, ipAttribution=)]
    2021-05-20 xjy13
  6. [GetPortalCommentsPageByObjectIdResponse(id=1668029, encodeId=68b11668029d9, content=<a href='/topic/show?id=1cf280498d2' target=_blank style='color:#2F92EE;'>#耳硬化症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80498, encryptionId=1cf280498d2, topicName=耳硬化症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f4726226525, createdName=jiyangfei, createdTime=Sat Jul 31 22:46:24 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823663, encodeId=5c8e182366324, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Wed Dec 09 01:46:24 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983131, encodeId=3cf41983131e0, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73594, encryptionId=a7a7e359478, topicName=硬化症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Sun Dec 20 08:46:24 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701464, encodeId=30451e01464a5, content=<a href='/topic/show?id=89fc8049e53' target=_blank style='color:#2F92EE;'>#耳硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80497, encryptionId=89fc8049e53, topicName=耳硬化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=515d30375051, createdName=jambiya, createdTime=Fri Sep 18 11:46:24 CST 2020, time=2020-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717043, encodeId=cd521e1704330, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Thu May 20 08:46:24 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814171, encodeId=3c9e8141e104, content=标记一下 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:53:09 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812792, encodeId=5537812e9265, content=耳硬化症发生率逐年在降低,是个好消息。, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Mon Aug 24 19:24:02 CST 2020, time=2020-08-24, status=1, ipAttribution=)]
    2020-08-27 ms4000002082197205

    标记一下 学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1668029, encodeId=68b11668029d9, content=<a href='/topic/show?id=1cf280498d2' target=_blank style='color:#2F92EE;'>#耳硬化症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80498, encryptionId=1cf280498d2, topicName=耳硬化症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f4726226525, createdName=jiyangfei, createdTime=Sat Jul 31 22:46:24 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823663, encodeId=5c8e182366324, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Wed Dec 09 01:46:24 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983131, encodeId=3cf41983131e0, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73594, encryptionId=a7a7e359478, topicName=硬化症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Sun Dec 20 08:46:24 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701464, encodeId=30451e01464a5, content=<a href='/topic/show?id=89fc8049e53' target=_blank style='color:#2F92EE;'>#耳硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80497, encryptionId=89fc8049e53, topicName=耳硬化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=515d30375051, createdName=jambiya, createdTime=Fri Sep 18 11:46:24 CST 2020, time=2020-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717043, encodeId=cd521e1704330, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Thu May 20 08:46:24 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814171, encodeId=3c9e8141e104, content=标记一下 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:53:09 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812792, encodeId=5537812e9265, content=耳硬化症发生率逐年在降低,是个好消息。, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Mon Aug 24 19:24:02 CST 2020, time=2020-08-24, status=1, ipAttribution=)]
    2020-08-24 Jessica

    耳硬化症发生率逐年在降低,是个好消息。

    0

相关资讯

Lancet:自1980年以来全球糖尿病的人数增加了4倍之多

非传染性疾病的其中一个全球目标是到2025停止年龄标准化成人糖尿病患病率的增长维持在2010年的水平。本研究旨在评估全球糖尿病的发展趋势,各国如何才能实现上述的全球目标,确定糖尿病患病率的变化,以及人口的增长和老龄化,影响着成人糖尿病患者的数量。

Baidu
map
Baidu
map
Baidu
map